238 related articles for article (PubMed ID: 22261743)
1. Monoubiquitination of nuclear RelA negatively regulates NF-κB activity independent of proteasomal degradation.
Hochrainer K; Racchumi G; Zhang S; Iadecola C; Anrather J
Cell Mol Life Sci; 2012 Jun; 69(12):2057-73. PubMed ID: 22261743
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin ligase HERC3 attenuates NF-κB-dependent transcription independently of its enzymatic activity by delivering the RelA subunit for degradation.
Hochrainer K; Pejanovic N; Olaseun VA; Zhang S; Iadecola C; Anrather J
Nucleic Acids Res; 2015 Nov; 43(20):9889-904. PubMed ID: 26476452
[TBL] [Abstract][Full Text] [Related]
3. p97/VCP promotes Cullin-RING-ubiquitin-ligase/proteasome-dependent degradation of IκBα and the preceding liberation of RelA from ubiquitinated IκBα.
Schweitzer K; Pralow A; Naumann M
J Cell Mol Med; 2016 Jan; 20(1):58-70. PubMed ID: 26463447
[TBL] [Abstract][Full Text] [Related]
4. Nuclear IKKbeta is an adaptor protein for IkappaBalpha ubiquitination and degradation in UV-induced NF-kappaB activation.
Tsuchiya Y; Asano T; Nakayama K; Kato T; Karin M; Kamata H
Mol Cell; 2010 Aug; 39(4):570-82. PubMed ID: 20797629
[TBL] [Abstract][Full Text] [Related]
5. The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-κB activity by blocking ubiquitination mediated proteasomal degradation of IκBα in human hepatoma cells.
Surjit M; Varshney B; Lal SK
BMC Biochem; 2012 May; 13():7. PubMed ID: 22590978
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway.
Sasaki CY; Barberi TJ; Ghosh P; Longo DL
J Biol Chem; 2005 Oct; 280(41):34538-47. PubMed ID: 16105840
[TBL] [Abstract][Full Text] [Related]
7. CLK2 mediates IκBα-independent early termination of NF-κB activation by inducing cytoplasmic redistribution and degradation.
Li SZ; Shu QP; Zhou HM; Liu YY; Fan MQ; Liang XY; Qi LZ; He YN; Liu XY; Du XH; Huang XC; Chen YZ; Du RL; Liang YX; Zhang XD
Nat Commun; 2024 May; 15(1):3901. PubMed ID: 38724505
[TBL] [Abstract][Full Text] [Related]
8. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.
Saccani S; Marazzi I; Beg AA; Natoli G
J Exp Med; 2004 Jul; 200(1):107-13. PubMed ID: 15226358
[TBL] [Abstract][Full Text] [Related]
9. Duration of nuclear NF-kappaB action regulated by reversible acetylation.
Chen Lf ; Fischle W; Verdin E; Greene WC
Science; 2001 Aug; 293(5535):1653-7. PubMed ID: 11533489
[TBL] [Abstract][Full Text] [Related]
10. Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability.
Park M; Yong Y; Choi SW; Kim JH; Lee JE; Kim DW
Nat Cell Biol; 2007 Mar; 9(3):287-98. PubMed ID: 17310243
[TBL] [Abstract][Full Text] [Related]
11. Methodology to study NF-κB/RelA ubiquitination in vivo.
Li H; Starokadomskyy P; Burstein E
Methods Mol Biol; 2015; 1280():371-81. PubMed ID: 25736761
[TBL] [Abstract][Full Text] [Related]
12. WSB1/2 target chromatin-bound lysine-methylated RelA for proteasomal degradation and NF-κB termination.
Zhang J; Yu Y; Zou X; Du Y; Liang Q; Gong M; He Y; Luo J; Wu D; Jiang X; Sinclair M; Tajkhorshid E; Chen HZ; Hou Z; Zheng Y; Chen LF; Yang XD
Nucleic Acids Res; 2024 May; 52(9):4969-4984. PubMed ID: 38452206
[TBL] [Abstract][Full Text] [Related]
13. Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export.
Chen Y; Li HH; Fu J; Wang XF; Ren YB; Dong LW; Tang SH; Liu SQ; Wu MC; Wang HY
Cell Res; 2007 Dec; 17(12):1020-9. PubMed ID: 18040287
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-kappaB activation.
Fan Y; Mao R; Zhao Y; Yu Y; Sun W; Song P; Shi Z; Zhang D; Yvon E; Zhang H; Fu S; Yang J
J Biol Chem; 2009 Oct; 284(43):29290-7. PubMed ID: 19706600
[TBL] [Abstract][Full Text] [Related]
15. ATM regulates NF-κB-dependent immediate-early genes via RelA Ser 276 phosphorylation coupled to CDK9 promoter recruitment.
Fang L; Choudhary S; Zhao Y; Edeh CB; Yang C; Boldogh I; Brasier AR
Nucleic Acids Res; 2014 Jul; 42(13):8416-32. PubMed ID: 24957606
[TBL] [Abstract][Full Text] [Related]
16. Suppression of p65 phosphorylation coincides with inhibition of IkappaBalpha polyubiquitination and degradation.
Hu J; Haseebuddin M; Young M; Colburn NH
Mol Carcinog; 2005 Dec; 44(4):274-84. PubMed ID: 16163708
[TBL] [Abstract][Full Text] [Related]
17. NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug.
Caporali S; Levati L; Graziani G; Muzi A; Atzori MG; Bonmassar E; Palmieri G; Ascierto PA; D'Atri S
J Transl Med; 2012 Dec; 10():252. PubMed ID: 23259744
[TBL] [Abstract][Full Text] [Related]
18. Critical roles of IκBα and RelA phosphorylation in transitional oscillation in NF-κB signaling module.
Hatanaka N; Seki T; Inoue JI; Tero A; Suzuki T
J Theor Biol; 2019 Feb; 462():479-489. PubMed ID: 30496749
[TBL] [Abstract][Full Text] [Related]
19. p28(GANK) associates with p300 to attenuate the acetylation of RelA.
Ren YB; Luo T; Li J; Fu J; Wang Q; Cao GW; Chen Y; Wang HY
Mol Carcinog; 2015 Dec; 54(12):1626-35. PubMed ID: 25400040
[TBL] [Abstract][Full Text] [Related]
20. Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death.
Kashyap T; Argueta C; Aboukameel A; Unger TJ; Klebanov B; Mohammad RM; Muqbil I; Azmi AS; Drolen C; Senapedis W; Lee M; Kauffman M; Shacham S; Landesman Y
Oncotarget; 2016 Nov; 7(48):78883-78895. PubMed ID: 27713151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
